Literature DB >> 34775184

Daily use of nicotine replacement medications is related to daily smoking status: An ecological momentary assessment study.

Emily T Hébert1, Tanushri Bhushan2, Chaelin K Ra2, Summer Frank-Pearce2, Adam C Alexander3, Ashley B Cole4, Darla E Kendzor3, Michael S Businelle3.   

Abstract

BACKGROUND: Few studies have examined how daily adherence to nicotine replacement therapy (NRT) impacts daily smoking abstinence.
METHODS: Data from a pilot randomized controlled trial of a smartphone-based smoking cessation intervention were used. Separate, generalized linear mixed models examined the association between ecological momentary assessments of NRT use and same-day and next day smoking status. Separate models examined the relationship between daily smoking status and (1) any use of NRT, (2) quantity of nicotine gum used, and (3) nicotine patch wear time. Reasons for medication non-adherence were also examined.
RESULTS: Participants (n = 77) were predominantly White (66.2%) and female (50.6%), 50.4 years old (SD=11.6) on average, and they smoked an average of 21.8 cigarettes per day (SD=11.0) at baseline. Daily NRT use was significantly associated with a lower likelihood of smoking both within that same day and the following day. While using the gum and patch together, and using the patch alone were associated with reduced odds of same-day and next-day smoking, using the gum alone was not significantly associated with reduced odds of smoking. The most commonly cited reasons for not using the patch or gum was "other" (43.3%), followed by "side effects" (27.1%), and "forgot" (18.9%).
CONCLUSION: Daily use of the patch or both the patch and gum was associated with a lower risk of daily smoking. Low levels of nicotine gum use alone may not be an effective cessation strategy. Future studies should further explore reasons for NRT non-compliance, and ways to increase NRT adherence.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Assessment; Ecological momentary; Nicotine replacement therapy; Smoking cessation; Tobacco

Mesh:

Substances:

Year:  2021        PMID: 34775184      PMCID: PMC8671265          DOI: 10.1016/j.drugalcdep.2021.109161

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  15 in total

1.  Electronically Monitored Nicotine Gum Use Before and After Smoking Lapses: Relationship With Lapse and Relapse.

Authors:  Tanya R Schlam; Timothy B Baker; Stevens S Smith; Daniel M Bolt; Danielle E McCarthy; Jessica W Cook; Todd Hayes-Birchler; Michael C Fiore; Megan E Piper
Journal:  Nicotine Tob Res       Date:  2020-10-29       Impact factor: 4.244

Review 2.  A systematic review of studies assessing the association between adherence to smoking cessation medication and treatment success.

Authors:  Tobias Raupach; Jamie Brown; Aleksandra Herbec; Leonie Brose; Robert West
Journal:  Addiction       Date:  2013-09-13       Impact factor: 6.526

3.  A Randomized Controlled Trial of an Optimized Smoking Treatment Delivered in Primary Care.

Authors:  Megan E Piper; Jessica W Cook; Tanya R Schlam; Douglas E Jorenby; Stevens S Smith; Linda M Collins; Robin Mermelstein; David Fraser; Michael C Fiore; Timothy B Baker
Journal:  Ann Behav Med       Date:  2018-09-13

4.  Can we increase smokers' adherence to nicotine replacement therapy and does this help them quit?

Authors:  Tanya R Schlam; Jessica W Cook; Timothy B Baker; Todd Hayes-Birchler; Daniel M Bolt; Stevens S Smith; Michael C Fiore; Megan E Piper
Journal:  Psychopharmacology (Berl)       Date:  2018-04-25       Impact factor: 4.530

5.  Real-world efficacy of prescription and over-the-counter nicotine replacement therapy.

Authors:  Saul Shiffman; Clyde N Rolf; Stephen J Hellebusch; Jane Gorsline; Charles W Gorodetzky; Yu-Kun Chiang; Debra S Schleusener; Michael E Di Marino
Journal:  Addiction       Date:  2002-05       Impact factor: 6.526

6.  Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.

Authors:  Nicola Lindson; Samantha C Chepkin; Weiyu Ye; Thomas R Fanshawe; Chris Bullen; Jamie Hartmann-Boyce
Journal:  Cochrane Database Syst Rev       Date:  2019-04-18

7.  Quitting Failure and Success With and Without Using Medication: Latent Classes of Abstinence and Adherence to Nicotine Monotherapy, Combination Therapy, and Varenicline.

Authors:  Danielle E McCarthy; Mark V Versella
Journal:  Nicotine Tob Res       Date:  2019-10-26       Impact factor: 4.244

Review 8.  Evaluating level of adherence to nicotine replacement therapy and its impact on smoking cessation: a systematic review and meta-analysis.

Authors:  Amanual Getnet Mersha; Parivash Eftekhari; Michelle Bovill; Daniel Nigusse Tollosa; Gillian Sandra Gould
Journal:  Arch Public Health       Date:  2021-03-04

Review 9.  Barriers and Facilitators of Adherence to Nicotine Replacement Therapy: A Systematic Review and Analysis Using the Capability, Opportunity, Motivation, and Behaviour (COM-B) Model.

Authors:  Amanual Getnet Mersha; Gillian Sandra Gould; Michelle Bovill; Parivash Eftekhari
Journal:  Int J Environ Res Public Health       Date:  2020-11-30       Impact factor: 3.390

10.  A Mobile Just-in-Time Adaptive Intervention for Smoking Cessation: Pilot Randomized Controlled Trial.

Authors:  Chaelin K Ra; Emily T Hébert; Adam C Alexander; Angela Helt; Rachel Moisiuc; Darla E Kendzor; Damon J Vidrine; Rachel K Funk-Lawler; Michael S Businelle
Journal:  J Med Internet Res       Date:  2020-03-09       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.